Antimicrobial and Anti-Biofilm Medical Devices: Public Health and Regulatory Science Challenges

Abstract

Healthcare associated infections (HAIs) are one of the top 10 causes of death in the United States (~100,000 deaths per year) [1, 2] and impose a significant financial burden ($28–45 billion in 2007) [3]. HAIs can happen anywhere in the continuum of settings where patients receive health care (e.g., long-term care, home care, ambulatory care) [4]. A subset… (More)

Topics

4 Figures and Tables

Cite this paper

@inproceedings{Phillips2017AntimicrobialAA, title={Antimicrobial and Anti-Biofilm Medical Devices: Public Health and Regulatory Science Challenges}, author={Phillips}, year={2017} }